Lead sponsor
Hongwei Jiang
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
2
Trials led
2
Ongoing
124
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 4
1
Trials by status
Not yet recruiting
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
An Exploratory Study of Single-Dose and Multiple-Doses IBI3042 in Healthy, Overweight, or Obese ParticipantsBMI 20-28Ph 1Not yet recruiting94